Clinical Trials Directory

Trials / Completed

CompletedNCT05643040

Comparison of Perioperative Analgesic Efficacy of Femoral Nerve Block, Adductor Canal Block and 4in1 Block

Comparison of Perioperative Analgesic Efficacy in Patients Who Had Femoral Nerve Block, Adductor Canal Block and 4in1 Block Applied in Knee Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital · Other Government
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Central neuraxial and regional anesthesia and analgesia techniques significantly reduce perioperative morbidity and mortality in the knee and below-knee surgeries.Nerve blocks appear to have better analgesic efficacy compared to placebo or patient-controlled analgesia (PCA). In addition, opioid-related side effects such as postoperative nausea, vomiting, pruritus, sedation, and respiratory depression are less. Therefore, interest in regional blocks such as femoral, sciatic, adductor, combined femoral, and sciatic is increasing. The knee joint is innervated by various nerves (genicular nerves) from the femoral, obturator, and sciatic nerves, and a comprehensive but simple technique is needed for postoperative analgesia. Complete and comprehensive postoperative analgesia was possible with this block, a simple single injection technique. The aim of our study is to evaluate the intraoperative analgesia efficacy of femoral, adductor canal block, and 4in1 block in patients who will undergo knee surgery.

Conditions

Interventions

TypeNameDescription
OTHERfemoral nerve blockTo evaluate the intraoperative analgesia effectiveness of femoral block in patients who will have knee surgery.
OTHERadductor canal blockTo evaluate the intraoperative analgesia effectiveness of adductor canal block in patients who will have knee surgery.
OTHER4in1 blockTo evaluate the intraoperative analgesia effectiveness of 4in1 block in patients who will have knee surgery.

Timeline

Start date
2022-09-01
Primary completion
2025-06-20
Completion
2025-06-30
First posted
2022-12-08
Last updated
2025-07-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05643040. Inclusion in this directory is not an endorsement.